Recently, minimally invasive cardiac surgery has started to gain popularity among surgeons and patients. Minimally invasive procedures allow for reduced hospitalization and less scarring. The growth of the minimally invasive procedures comes from the cannibalization of the open-heart surgery procedures. Currently, many types of minimally invasive procedures do not have FDA approval. As more products get FDA approved, the minimally invasive procedures are expected to grow at a much higher rate and cause the open-heart procedures to decline.
'
TABLE OF CONTENTS I
LIST OF FIGURES XII
LIST OF CHARTS XX
EXECUTIVE SUMMARY 1
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 11
PROCEDURE NUMBERS 12
PROCEDURE CODES INVESTIGATED 16
MARKETS INCLUDED 17
KEY REPORT UPDATES 19
VERSION HISTORY 20
RESEARCH METHODOLOGY 21
Step 1: Project Initiation & Team Selection 21
Step 2: Prepare Data Systems and Perform Secondary Research 24
Step 3: Preparation for Interviews & Questionnaire Design 26
Step 4: Performing Primary Research 27
Step 5: Research Analysis: Establishing Baseline Estimates 29
Step 6: Market Forecasts and Analysis 30
Step 7: Identify Strategic Opportunities 32
Step 8: Final Review and Market Release 33
Step 9: Customer Feedback and Market Monitoring 34
DISEASE OVERVIEW 35
2.1 BASIC ANATOMY 35
2.1.11 Coronary Artery Disease 37
2.1.12 Myocardial Infarction 37
2.1.13 Angina Pectoris 38
2.1.14 Heart Valve Disease 39
2.1.15 Congestive Heart Failure 39
PROCEDURE NUMBERS 41
3.1 INTRODUCTION 41
3.2 CARDIAC SURGERY AND HEART VALVE PROCEDURES 42
3.3 SURGICAL HEART VALVE REPLACEMENT PROCEDURES 47
3.3.1 Tissue Heart Valve Procedures by Valve Type 49
3.3.2 Tissue Heart Valve Procedures by Device Type 52
3.3.3 Tissue Heart Valve Procedures by Tissue Type 54
3.3.4 Mechanical Heart Valve Procedures by Valve Type 56
3.3.5 Mechanical Heart Valve Procedures by Tissue Type 59
3.4 ANNULOPLASTY REPAIR PROCEDURES 61
3.4.1 Annuloplasty Repair Procedures by Valve Type 61
3.4.2 Annuloplasty Repair Procedures by Device Type 63
3.5 TRANSCATHETER MITRAL HEART VALVE REPAIR PROCEDURES 65
3.6 TRANSCATHETER AORTIC HEART VALVE REPLACEMENT PROCEDURES 68
3.6.1 Transcatheter Aortic Heart Valve Replacement Procedures by Approach 70
3.6.2 Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class 73
3.7 CABG PROCEDURES 75
3.7.1 CABG Procedures by Support Type 75
3.7.2 CABG Vessel Harvesting Procedures by Type 79
3.7.3 CABG Procedures by Suture Type 81
3.8 TRANSMYOCARDIAL REVASCULARIZATION PROCEDURES 83
3.9 VENTRICULAR ASSIST DEVICE PROCEDURES 85
3.9.1 Ventricular Assist Procedures by Device Type 85
3.9.1.1 Percutaneous Ventricular Assist Procedures by Indication 87
3.9.1.2 Implantable Ventricular Assist Procedures by Indication 89
3.9.1.3 Implantable Ventricular Assist Procedures by Area 91
3.9.1.4 External Ventricular Assist Procedures by Device Type 93
3.10 INTRA-AORTIC BALLOON PUMP PROCEDURES 95
3.10.1 Intra-Aortic Balloon Pump Procedures by Setting 95
3.10.2 Intra-Aortic Balloon Pump Procedures by Device Type 98
3.11 TEMPORARY ARTIFICIAL HEART PROCEDURES 100
3.12 REMOTE HEMODYNAMIC MONITORING PROCEDURES 103
3.13 PATENT FORAMEN OVALE CLOSURE PROCEDURES 105
3.14 SEPTAL DEFECT CLOSURE PROCEDURES 107
3.14.1 Septal Defect Closure Procedures by Type 107
3.15 LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES 109
3.15.1 Left Atrial Appendage Closure Procedures by Type 109
3.15.1.1 Epicardial Device Procedures by Type 112
3.15.1.1.1 Epicardial Clip Device Procedures by Type 113
ABBREVIATIONS 115
APPENDIX: COMPANY PRESS RELEASES 118
Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 – 2024 3
Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024 3
Chart 5 1: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 46
Chart 5 2: Surgical Heart Valve Replacement Procedures by Device Type, U.S., 2014 – 2024 48
Chart 5 3: Tissue Heart Valve Procedures by Valve Type, U.S., 2014 – 2024 51
Chart 5 4: Tissue Heart Valve Procedures by Device Type, U.S., 2014 – 2024 53
Chart 5 5: Tissue Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024 55
Chart 5 6: Mechanical Heart Valve Procedures by Valve Type, U.S., 2014 – 2024 58
Chart 5 7: Mechanical Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024 60
Chart 5 8: Annuloplasty Repair Procedures by Valve Type, U.S., 2014 – 2024 62
Chart 5 9: Annuloplasty Repair Procedures by Device Type, U.S., 2014 – 2024 64
Chart 5 10: Transcatheter Heart Valve Repair Procedures, U.S., 2014 – 2024 67
Chart 5 11: Transcatheter Aortic Heart Valve Replacement Procedures by Valve Type, U.S., 2014 – 2024 69
Chart 5 12: Transcatheter Aortic Heart Valve Replacement Procedures by Approach, U.S., 2014 – 2024 72
Chart 5 13: Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class, U.S., 2017 74
Chart 5 14: CABG Procedures by Support Type, U.S., 2014 – 2024 77
Chart 5 15: CABG Vessel Harvesting Procedures by Type, U.S., 2014 – 2024 80
Chart 5 16: CABG Procedures by Suture Type, U.S., 2014 – 2024 82
Chart 5 17: Transmyocardial Revascularization Procedures, U.S., 2014 – 2024 84
Chart 5 18: Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024 86
Chart 5 19: Percutaneous Ventricular Assist Procedures by Indication, U.S., 2014 – 2024 88
Chart 5 20: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024 90
Chart 5 21: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024 92
Chart 5 22: External Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024 94
Chart 5 23: Intra-Aortic Balloon Pump Procedures by Setting, U.S., 2014 – 2024 97
Chart 5 24: Intra-Aortic Balloon Pump Procedures by Device Type, U.S., 2014 – 2024 99
Chart 5 25: Heart Replacement Procedures by Type, U.S., 2014 – 2024 102
Chart 5 26: Remote Hemodynamic Monitoring Device Implantation Procedures, U.S., 2014 – 2024 104
Chart 5 27: Patent Foramen Ovale Closure Procedures, U.S., 2014 – 2024 106
Chart 5 28: Septal Defect Closure Procedures by Type, U.S., 2014 – 2024 108
Chart 5 29: Left Atrial Appendage Closure Procedures by Type, U.S., 2014 – 2024 111
Chart 5 30: Epicardial Device Procedures by Type, U.S., 2014 – 2024 112
Chart 5 31: Epicardial Clip Device Procedures by Type, U.S., 2014 – 2024 114
Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4) 4
Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4) 5
Figure 1 5: Companies Researched in this Report, U.S., 2017 6
Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4) 7
Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4) 8
Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4) 9
Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4) 10
Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 – 2017 11
Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4) 12
Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4) 13
Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4) 14
Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4) 15
Figure 1 15: Procedure Codes Investigated, U.S., 2017 16
Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2) 17
Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2) 18
Figure 1 18: Key Report Updates (1 of 2) 19
Figure 1 19: Key Report Updates (2 of 2) 20
Figure 1 20: Version History 20
Figure 5 1: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 (1 of 3) 43
Figure 5 2: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 (2 of 3) 44
Figure 5 3: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 (3 of 3) 45
Figure 5 4: Surgical Heart Valve Replacement Procedures by Device Type, U.S., 2014 – 2024 47
Figure 5 5: Tissue Heart Valve Procedures by Valve Type, U.S., 2014 – 2024 50
Figure 5 6: Tissue Heart Valve Procedures by Device Type, U.S., 2014 – 2024 52
Figure 5 7: Tissue Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024 54
Figure 5 8: Mechanical Heart Valve Procedures by Valve Type, U.S., 2014 – 2024 57
Figure 5 9: Mechanical Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024 59
Figure 5 10: Annuloplasty Repair Procedures by Valve Type, U.S., 2014 – 2024 61
Figure 5 11: Annuloplasty Repair Procedures by Device Type, U.S., 2014 – 2024 63
Figure 5 12: Transcatheter Mitral Heart Valve Repair Procedures, U.S., 2014 – 2024 66
Figure 5 13: Transcatheter Aortic Heart Valve Replacement Procedures by Valve Type, U.S., 2014 – 2024 68
Figure 5 14: Transcatheter Aortic Heart Valve Replacement Procedures by Approach, U.S., 2014 – 2024 71
Figure 5 15: Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class, U.S., 2017 73
Figure 5 16: CABG Procedures by Support Type, U.S., 2014 – 2024 76
Figure 5 17: CABG Procedure Penetration Rates, U.S., 2014 – 2024 78
Figure 5 18: CABG Vessel Harvesting Procedures by Type, U.S., 2014 – 2024 79
Figure 5 19: CABG Procedures by Suture Type, U.S., 2014 – 2024 81
Figure 5 20: Transmyocardial Revascularization Procedures, U.S., 2014 – 2024 83
Figure 5 21: Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024 85
Figure 5 22: Percutaneous Ventricular Assist Procedures by Indication, U.S., 2017 87
Figure 5 23: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024 89
Figure 5 24: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024 91
Figure 5 25: External Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024 93
Figure 5 26: Intra-Aortic Balloon Pump Procedures by Setting, U.S., 2014 – 2024 96
Figure 5 27: Intra-Aortic Balloon Pump Procedures by Device Type, U.S., 2014 – 2024 98
Figure 5 28: Heart Replacement Procedures by Type, U.S., 2014 – 2024 101
Figure 5 29: Remote Hemodynamic Monitoring Device Implantation Procedures, U.S., 2014 – 2024 103
Figure 5 30: Patent Foramen Ovale Closure Procedures, U.S., 2014 – 2024 105
Figure 5 31: Septal Defect Closure Procedures by Type, U.S., 2014 – 2024 107
Figure 5 32: Left Atrial Appendage Closure Procedures by Type, U.S., 2014 – 2024 110
Figure 5 33: Epicardial Device Procedures by Type, U.S., 2014 – 2024 112
Figure 5 34: Epicardial Clip Device Procedures by Type, U.S., 2014 – 2024 113
Figure 25 1: Press Release Summary 118
Edwards Lifesciences
St. Jude Medical
Medtronic
Maquet
Abiomed
HeartWare Inc.
Sorin Group
Terumo
Abbott Laboratories
Teleflex Medical
Cardiac Assist
AtriCure
W.L. Gore
SynCardia
Boston Scientific
Cryolife
Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.
